Missed opportunities for HPV vaccination in adolescent girls: A qualitative study

Pediatrics

Volumn 134, Issue 3, 2014, Pages e666-e674

  Perkins, Rebecca B ^a   Clark, Jack A ^b,c   Apte, Gauri ^c   Vercruysse, Jessica L ^a   Sumner, Justen J ^a   Wall Haas, Constance L ^d   Rosenquist, Anna W ^e   Pierre Joseph, Natalie ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d Harvard Vanguard Medical Associates   (United Kingdom)

^e HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

Author keywords

HPV vaccination; Missed opportunities; Parental attitudes; Provider attitudes; Qualitative methods

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BLACK PERSON; CANCER PREVENTION; CAUCASIAN; CONTROLLED STUDY; EDUCATION; ETHNICITY; FEMALE; HEALTH CARE PERSONNEL; HEALTH SERVICE; HISPANIC; HUMAN; INCOME; INTERVIEW; MALE; MEDICAID; MEDICAL PRACTICE; PAPILLOMAVIRUS INFECTION; PARENT; PRIVATE HEALTH INSURANCE; PRIVATE PRACTICE; PUBLIC HEALTH INSURANCE; QUALITATIVE RESEARCH; RELIGION; SEXUAL BEHAVIOR; THERAPY DELAY; UTERINE CERVIX CANCER; VACCINATION; AGED; ATTITUDE TO HEALTH; CHILD; CHILD PARENT RELATION; HPV VACCINATION; MIDDLE AGED; MISSED OPPORTUNITIES; PARENTAL ATTITUDES; PATIENT ATTITUDE; PROVIDER ATTITUDES; PSYCHOLOGICAL ASPECT; QUALITATIVE METHODS; UTERINE CERVIX TUMOR; UTILIZATION REVIEW;

HPV VACCINATION; MISSED OPPORTUNITIES; PARENTAL ATTITUDES; PROVIDER ATTITUDES; QUALITATIVE METHODS;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS VACCINES; PARENT-CHILD RELATIONS; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITATIVE RESEARCH; SEXUAL BEHAVIOR; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84907224242     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-0442     Document Type: Article

References (29)

1. Stat Fact Sheets SEER. Cervix uteri cancer. Available at: http://seer.cancer.gov/statfacts/html/cervix.html. Accessed November 4, 2013
2. Clifford G, Franceschi S, Diaz M, Muñoz N, Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine. 2006;24(suppl 3): S3-, 26-34
3. Kahn JA, Cooper HP, Vadaparampil ST, et al. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11- to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev. 2009;18(8):2325-2332
4. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2007;56(RR-2):1-24
5. Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010; 59(20):626-629
6. Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis. 2013;208(3):385-393
7. Eaton DK, Kann L, Kinchen S, et al; Centers for Disease Control and Prevention (CDC). Youth risk behavior surveillance - United States, 2011. MMWR Surveill Summ. 2012;61(4):1-162
8. Centers for Disease Control and Prevention. Vaccination coverage among adolescents aged 13-17 years, United States, 2012 NIS-Teen. Available at: www.cdc.gov/vaccines/stats-surv/nisteen/data/tables-2012.htm. Accessed September 12, 2013
9. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2-3): 107-114
10. Kahn JA, Zimet GD, Bernstein DI, et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health. 2005;37(6):502-510
11. Dorell C, Yankey D, Strasser S. Parentreported reasons for nonreceipt of recommended adolescent vaccinations, national immunization survey: teen, 2009. Clin Pediatr (Phila). 2011;50(12):1116-1124
12. Guest GB, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006; 18:59-82
13. Perkins RB, Clark JA. Providers' perceptions of parental concerns about HPV vaccination. J Health Care Poor Underserved. 2013;24(2):828-839
14. Perkins RB, Clark JA. What affects human papillomavirus vaccination rates? A qualitative analysis of providers' perceptions. Womens Health Issues. 2012;22(4):e379-e386
15. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine. 2011;29(5):890-895
16. Daley MF, Liddon N, Crane LA, et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics. 2006;118(6): 2280-2289
17. Huey NL, Clark AD, Kluhsman BC, Lengerich EJ; ACTION Health Cancer Task Force. HPV vaccine attitudes and practices among primary care providers in Appalachian Pennsylvania. Prev Chronic Dis. 2009;6(2): A49
18. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13-17 years - United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(34):685-693
19. Mollborn S, Everett B. Correlates and consequences of parent-teen incongruence in reports of teens' sexual experience. J Sex Res. 2010;47(4):314-329
20. Liddon N, Michael SL, Dittus P, Markowitz LE. Maternal underestimation of child's sexual experience: suggested implications for HPV vaccine uptake at recommended ages. J Adolesc Health. 2013;53(5):674-676
21. Gertig DM, Brotherton JM, Budd AC, Drennan K, Chappell G, Saville AM. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. BMC Med. 2013;11:227
22. Opel DJ, Heritage J, Taylor JA, et al. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132(6):1037-1046
23. Saraiya M, Rosser JI, Cooper CP. Cancers that US physicians believe the HPV vaccine prevents: findings from a physician survey, 2009. J Womens Health (Larchmt). 2012;21 (2):111-117
24. Massachusetts Department of Public Health. Take the HPV challenge. Available at: http://mcaap.org/wp2013/wp-content/uploads/2014/02/MA-HPV-Provider-Challenge-Flyer-03-11-14.pdf. Accessed June 2, 2014
25. Sussman AL, Helitzer D, Sanders M, Urquieta B, Salvador M, Ndiaye K. HPV and cervical cancer prevention counseling with younger adolescents: implications for primary care. Ann Fam Med. 2007;5(4):298-304
26. Perkins RB, Clark JA. Providers' attitudes toward human papillomavirus vaccination in young men: challenges for implementation of 2011 recommendations. Am J Men Health. 2012;6(4):320-323
27. President's Cancer Panel Annual Report 2012-2013. Accelerating HPV vaccine uptake: urgency for action to prevent cancer. Available at: http://deainfo.nci.nih.gov/advisory/pcp/annualReports/HPV/index.htm#sthash.4ISsdGrG.dpbs. Accessed February 24, 2014
28. Centers for Disease Control and Prevention. You are the key to HPV cancer prevention: turning HPV vaccine challenges into opportunities. Available at: www.publichealthmdc.com/DCIC/documents/DCICmin20130514HPVCommPart2.pdf. Accessed June 1, 2014
29. CDC. Provider Recommendation of HPV Vaccine: Barriers and Facilitators. In: Baltimore. Kansas City, Seattle: Centers for Disease Control and Prevention; 2012: 1-12